|
PUS10 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.698720E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.548100E-02 |
| Normal-vs-Stage2 |
4.217600E-03 |
| Normal-vs-Stage3 |
1.142720E-03 |
| Normal-vs-Stage4 |
1.005050E-04 |
| Stage1-vs-Stage2 |
4.236000E-02 |
| Stage1-vs-Stage3 |
9.064000E-02 |
| Stage1-vs-Stage4 |
7.237900E-03 |
| Stage2-vs-Stage3 |
4.569000E-01 |
| Stage2-vs-Stage4 |
9.888200E-01 |
| Stage3-vs-Stage4 |
3.374400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.184200E-03 |
| Normal-vs-AfricanAmerican |
8.642000E-01 |
| Normal-vs-Asian |
9.219900E-02 |
| Caucasian-vs-AfricanAmerican |
1.451560E-01 |
| Caucasian-vs-Asian |
5.835200E-01 |
| AfricanAmerican-vs-Asian |
3.643400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.262300E-02 |
| Normal-vs-Female |
6.618500E-04 |
| Male-vs-Female |
1.355640E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.889700E-02 |
| Normal-vs-Age(41-60Yrs) |
7.601700E-03 |
| Normal-vs-Age(61-80Yrs) |
2.88729999997628E-06 |
| Normal-vs-Age(81-100Yrs) |
5.359000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.475800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.743340E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.372000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.317820E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.243000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.430600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.803300E-03 |
| Classical-VS-Follicular |
9.221000E-01 |
| Classical-VS-Other |
9.011000E-01 |
| Classical-VS-Normal |
1.221940E-02 |
| Tall-VS-Follicular |
6.181900E-02 |
| Tall-VS-Other |
2.751000E-01 |
| Tall-VS-Normal |
1.404520E-04 |
| Follicular-VS-Other |
9.086200E-01 |
| Follicular-VS-Normal |
1.138810E-01 |
| Other-VS-Normal |
2.437800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.063700E-03 |
| Normal-vs-N1 |
8.060300E-02 |
| N0-vs-N1 |
7.648600E-01 |
|
|
